Specific and non-specific desensitization of guinea-pig ileal smooth muscle. 1984

H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle

The effects of cis-2-methyl-4-dimethylaminomethyl-1-3-dioxolane methiodide (CD), a muscarinic agonist, histamine, substance P and K+-stimulation on the mechanical responses, Ca2+-dependence and desensitization in guinea-pig ileal longitudinal smooth muscle have been studied. The mechanical responses to all four stimulants are highly dependent upon extracellular Ca2+(Ca2+EXT) and are blocked by the Ca2+ channel antagonist nicardipine. The tonic (slow) components of response are more dependent on Ca2+EXT and are more sensitive to nicardipine (IC50 values 5.0 X 10(-8) - 2.5 X 10(-9)M) than are the phasic (fast) components of response. Tissue exposure to CD (5 X 10(-7)M, 10 min) or histamine (3 X 10(-6)M and 3 X 10(-4)M, 10 min) produces short term nonspecific desensitization but substance P (5 X 10(-8)M, 10 min) produces only specific desensitization. K+-induced responses neither desensitize nor are desensitized. Desensitization is concentration- and time-dependent for both specific and nonspecific processes. Nonspecific desensitization is protected by elevation of K+ concentration (5.36mM) in the incubating medium, by dithiothreitol and by inhibitors (mepacrine,p-bromophenacyl bromide and phenylgloxal) of phospholipase A2 and is potentiated by mellitin, an activator of phospholipase A2. Desensitization produced by the muscarinic agonist CS is protected by Gpp(NH)p (10(-4)M), but histamine-induced desensitization is unaffected. There is no loss of muscarinic receptors, measured by [3H]QNB binding following tissue exposure to low concentrations of CD (5.0 X 10(-7)M) for up to 72 h. However, an apparent loss of receptors (20-30%) is measured following 10-90 min exposure of tissue to 10(-3)M CD. It is suggested that contractions of guinea-pig ileal longitudinal smooth muscle elicited by CD, histamine, substance P or K+ mobilize a common pool of Ca2+ through a Ca2+ channel antagonist (nicardipine) sensitive pathway. However, the existence of short term nonspecific desensitization (CD and histamine), specific desensitization (substance P) or no desensitization (K+ stimulation) indicates that significant differences exist in the pathways linking initial stimulus to mechanical response. The ability of elevated K+ to protect against nonspecific desensitization suggest that post stimulus membrane hyperpolarization may represent one contributing component to nonspecific desensitization. Products of phospholipid degradation may also contribute to desensitization since inhibitors or activators of phospholipase A2 prevented or potentiated respectively, nonspecific desensitization.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009529 Nicardipine A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. Antagonil,Cardene,Cardene I.V.,Cardene SR,Dagan,Flusemide,Lecibral,Lincil,Loxen,Lucenfal,Nicardipine Hydrochloride,Nicardipine LA,Nicardipino Ratiopharm,Nicardipino Seid,Perdipine,Ridene,Vasonase,Y-93,Hydrochloride, Nicardipine,LA, Nicardipine,Y 93,Y93
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation

Related Publications

H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
November 1990, British journal of pharmacology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
June 1995, Gastroenterology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
June 1983, The Journal of pharmacology and experimental therapeutics,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
February 1991, Pflugers Archiv : European journal of physiology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
May 1984, The Journal of pharmacy and pharmacology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
June 1992, Journal of autonomic pharmacology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
December 1986, Canadian journal of physiology and pharmacology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
January 1990, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
January 1991, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
H Siegel, and K Jim, and G T Bolger, and P Gengo, and D J Triggle
September 1981, The American journal of physiology,
Copied contents to your clipboard!